This transcript has been edited for clarity. Stanley Cohen, MD: I am Dr Stanley Cohen and welcome to Medscape's InDiscussion series on psoriatic arthritis. This is episode 3 of the second season.

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Between May 2019 and March 2020, patients receiving MTX and/or ...

Patients with psoriatic arthritis who received bimekizumab demonstrated sustained improvements in clinical outcomes for up to 52 weeks, with or without the use of concomitant methotrexate. Patients ...

While there’s no cure for psoriatic arthritis, there are treatments that can help ease the joint pain, swelling, and stiffness it causes. Some also help keep the disease from further harming your ...

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify [email protected] if there are concerns ...

Psoriatic arthritis is a type of arthritis that develops in some people who have psoriasis, which is a chronic autoimmune disease of the skin. Psoriatic arthritis can be mild or severe. It can also be ...

Psoriatic arthritis represents a complex intersection of immune dysfunction where inflammation targets both skin and joints, creating a condition that challenges patients and clinicians alike. This ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. So talking about treatment options in a ...

Malvern, PA - The US FDA has approved the TNF blocker infliximab (Remicade, Centocor) "to reduce the signs and symptoms of active arthritis in patients with psoriatic arthritis." The drug can be used ...